HN2002000162A - Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales - Google Patents

Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales

Info

Publication number
HN2002000162A
HN2002000162A HN2002000162A HN2002000162A HN2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A HN 2002000162 A HN2002000162 A HN 2002000162A
Authority
HN
Honduras
Prior art keywords
methods
mycoplasma bovis
animals
bovis vaccine
pneumonia
Prior art date
Application number
HN2002000162A
Other languages
English (en)
Spanish (es)
Inventor
Lee Keich Robin
Ross Mcgavin David
John Yancey Robert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HN2002000162A publication Critical patent/HN2002000162A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/36—Adaptation or attenuation of cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55577—Saponins; Quil A; QS21; ISCOMS

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
HN2002000162A 2001-07-02 2002-06-28 Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales HN2002000162A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263801P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
HN2002000162A true HN2002000162A (es) 2002-09-17

Family

ID=23168600

Family Applications (1)

Application Number Title Priority Date Filing Date
HN2002000162A HN2002000162A (es) 2001-07-02 2002-06-28 Vacuna de mycoplasma bovis y metodos para reducir la neumonia en animales

Country Status (31)

Country Link
US (1) US20030147914A1 (cg-RX-API-DMAC7.html)
EP (1) EP1401488A1 (cg-RX-API-DMAC7.html)
JP (1) JP2004536106A (cg-RX-API-DMAC7.html)
KR (1) KR20040030783A (cg-RX-API-DMAC7.html)
CN (1) CN1522152A (cg-RX-API-DMAC7.html)
AP (1) AP2002002568A0 (cg-RX-API-DMAC7.html)
AR (1) AR036125A1 (cg-RX-API-DMAC7.html)
BG (1) BG108496A (cg-RX-API-DMAC7.html)
BR (1) BR0210798A (cg-RX-API-DMAC7.html)
CA (1) CA2452580A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20033465A3 (cg-RX-API-DMAC7.html)
EA (1) EA200301324A1 (cg-RX-API-DMAC7.html)
GT (1) GT200200139A (cg-RX-API-DMAC7.html)
HN (1) HN2002000162A (cg-RX-API-DMAC7.html)
HR (1) HRP20031078A2 (cg-RX-API-DMAC7.html)
HU (1) HUP0501188A2 (cg-RX-API-DMAC7.html)
IL (1) IL159516A0 (cg-RX-API-DMAC7.html)
IS (1) IS7078A (cg-RX-API-DMAC7.html)
MA (1) MA27048A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA03011815A (cg-RX-API-DMAC7.html)
NO (1) NO20035767L (cg-RX-API-DMAC7.html)
OA (1) OA12640A (cg-RX-API-DMAC7.html)
PA (1) PA8549801A1 (cg-RX-API-DMAC7.html)
PE (1) PE20030239A1 (cg-RX-API-DMAC7.html)
PL (1) PL373891A1 (cg-RX-API-DMAC7.html)
SK (1) SK15802003A3 (cg-RX-API-DMAC7.html)
TN (1) TNSN03154A1 (cg-RX-API-DMAC7.html)
UY (1) UY27365A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003004052A1 (cg-RX-API-DMAC7.html)
YU (1) YU102103A (cg-RX-API-DMAC7.html)
ZA (1) ZA200309747B (cg-RX-API-DMAC7.html)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179473B2 (en) 1998-06-05 2007-02-20 Boehringer Ingelheim Vetmedica Gmbh Attenuated pestiviruses
US7135561B2 (en) 2001-09-06 2006-11-14 Boehringer Ingelheim Vetmedica Gmbh Infectious bovine viral diarrhea virus clone
US7279166B2 (en) * 2001-12-12 2007-10-09 Virginia Tech Intellectual Properties, Inc. Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
US7572455B2 (en) * 2004-05-19 2009-08-11 Boehringer Ingelheim Vetmedica Gmbh Vaccine comprising an attenuated pestivirus
US20090068223A1 (en) * 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
US20110059437A1 (en) * 2006-09-07 2011-03-10 Boehringer Ingelheim Vetmedica, Inc. Pcr-based genotyping
UA98115C2 (ru) 2006-09-11 2012-04-25 Пфайзер Продактс Инк. Композиция, которая содержит подвергнутые тепловой обработке бактерины
CL2008003202A1 (es) * 2007-10-29 2009-11-27 Boehringer Ingelheim Vetmedica Inc Composicion inmunogenica que comprende bacterias vivas de mycoplasma bovis atenuada avirulenta.
UY31930A (es) * 2008-06-25 2010-01-29 Boheringer Ingelheim Pharma Kg Pestivirus atenuados recombinantes, en particular a csfv, bvdv o bdv atenuado recombinante
EP2320943B1 (en) * 2008-07-03 2016-02-17 Iowa State University Research Foundation, Inc. Cattle vaccines
SG10201506597RA (en) * 2008-10-31 2015-10-29 Boehringer Ingelheim Vetmed Use Of Various Antigens Including Antigens From Mycoplasma Bovis In Multivalent Vaccine Composition
US8846054B2 (en) * 2009-01-09 2014-09-30 Boehringer Ingelheim Vetmedica, Inc. Method of treating pregnant cows and/or heifers
UY32570A (es) * 2009-04-24 2010-11-30 Boehringer Ingelheim Vetmed Vacuna viva modificada de mycoplasma bovis mejorada
WO2010140377A1 (ja) 2009-06-04 2010-12-09 独立行政法人産業技術総合研究所 マイコプラズマ感染症用ワクチン
CN102220263B (zh) * 2011-05-06 2012-10-03 华中农业大学 一种牛支原体致弱菌株及其应用
PT2938747T (pt) 2012-12-28 2019-08-01 Boehringer Ingelheim Vetmedica Gmbh Método de preparação de uma vacina de micoplasma
CN104857509A (zh) * 2015-06-02 2015-08-26 福清市默克兽医院 牛支原体肺炎组织灭活疫苗的制备方法、配方及使用方法
DK3334454T3 (da) 2015-08-14 2022-11-14 Zoetis Services Llc Mycoplasma-Bovis-sammensætninger
AU2016380864B2 (en) 2015-12-28 2019-10-31 Boehringer Ingelheim Animal Health USA Inc. M hyo multivalent vaccine and uses thereof
CN105441368B (zh) * 2016-01-19 2019-01-01 福清市默克兽医院 一株牛支原体及其应用
CN106929452B (zh) * 2017-04-11 2020-06-12 河南省农业科学院畜牧兽医研究所 一株牛支原体及其应用
CN109022314B (zh) * 2018-08-06 2021-08-13 北京华夏兴洋生物科技有限公司 一株牛支原体及其在疫苗研制中的应用
CN110338138B (zh) * 2019-06-19 2021-04-06 山东省农业科学院奶牛研究中心 一种牛支原体感染豚鼠的动物模型构建方法及其应用
CN112301041B (zh) * 2020-10-09 2022-05-24 华中农业大学 牛支原体p21蛋白及其应用
CN113546162B (zh) * 2021-05-31 2023-07-18 江苏省农业科学院 一种支原体疫苗及其制备方法
CN113604492B (zh) * 2021-09-10 2023-07-07 苏州世诺生物技术有限公司 融合基因、融合蛋白及制备方法和牛支原体亚单位疫苗

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565205A (en) * 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
CA2390613A1 (en) * 1999-11-08 2001-05-17 Biomune Vaccines for mycoplasma bovis and methods of use
DE29921392U1 (de) * 1999-12-06 2000-03-16 Dr. Felgenträger & Co. Öko-Chem. und Pharma GmbH, 06862 Rodleben Mykoplasma-bovis-Kombinations-Vakzine für Rinder
US6548069B2 (en) * 2001-02-03 2003-04-15 Hmv Associates, Inc. Multivalent Mycoplasma bacterin

Also Published As

Publication number Publication date
EP1401488A1 (en) 2004-03-31
AR036125A1 (es) 2004-08-11
WO2003004052A1 (en) 2003-01-16
JP2004536106A (ja) 2004-12-02
ZA200309747B (en) 2005-05-27
CN1522152A (zh) 2004-08-18
YU102103A (sh) 2006-05-25
CZ20033465A3 (cs) 2004-12-15
KR20040030783A (ko) 2004-04-09
BG108496A (en) 2005-02-28
PE20030239A1 (es) 2003-03-21
GT200200139A (es) 2003-02-13
IS7078A (is) 2003-12-15
PA8549801A1 (es) 2003-09-17
IL159516A0 (en) 2004-06-01
CA2452580A1 (en) 2003-01-16
OA12640A (en) 2006-06-15
TNSN03154A1 (fr) 2005-12-23
UY27365A1 (es) 2003-04-30
EA200301324A1 (ru) 2004-12-30
HRP20031078A2 (en) 2005-08-31
NO20035767L (no) 2004-01-30
MA27048A1 (fr) 2004-12-20
SK15802003A3 (sk) 2005-01-03
AP2002002568A0 (en) 2002-06-30
MXPA03011815A (es) 2004-04-02
US20030147914A1 (en) 2003-08-07
PL373891A1 (en) 2005-09-19
HUP0501188A2 (en) 2006-05-29
BR0210798A (pt) 2006-05-23

Similar Documents

Publication Publication Date Title
BRPI0506305A (pt) artigos e métodos de tratamento da pele
MA27048A1 (fr) Vaccin a mycoplasma bovis et methodes pour reduire la pneumonie chez des animaux
BRPI0411900A (pt) compostos antivirais e métodos
TNSN07150A1 (en) Semi-soft c-class immunostimulatory oligonucleotides
HN2001000243A (es) Inhibidores de metaloproteinasa del tipo pirimidin - 2, 4, 6 - triona
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
CL2011000877A1 (es) Composicion inmunogena para el tratamiento y/o profilaxis de ganado contra infecciones microbiologicas porque comprende antigeno de mycoplasma bovis; metodo de coadministracion de dos o mas antigenos a un ganado bovino.
BRPI0512841A (pt) composições e métodos para o tratamento de infecções patológicas
ECSP044985A (es) Azitromicina de dosis única para infecciones respiratorias
DK1675603T3 (da) Anvendelse af probiotiske bakterier i behandling af infektion
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
HN2002000278A (es) Tetrahidroquinolinas
AR036355A1 (es) Modelo de exposicion a mycoplasma bovis, para evaluar la eficacia de potenciales vacunas
ATE411279T1 (de) Arylsulfonamidobenzylverbindungen
EP1968566A4 (en) COMPOSITIONS OF CIS-9, TRANS-11 CONJUGATED LINOLIC ACID AND VACCENIC ACID AND ITS USES
ATE391767T1 (de) Geflügelkrankheit verursachendes bakterium und daraus stammender impfstoff
ATE364389T1 (de) Verfahren zur herstellung von extrakten aus pelargonium sidoides und/oder pelargonium reniforme
CR11384A (es) Proteina m de estreptococo, fragmentos inmunogenicos, acidos nucleicos y metodos de uso
ATE359815T1 (de) Streptococcus-phocae-vakzine
DE502005008925D1 (de) Substituierte nonadepsipeptide
GT200000114A (es) Forma cristalina iii de la n-(4-(5-dimetilaminoftalen-1-sulfonilamino) fenil)-3-hidroxi-2, 2-dimetilpropionamida.
DK1740206T3 (da) PHEP, en aminosyrepermease af Staphylococcus Aureus
EA200401523A1 (ru) Способы применения и композиции для диагностики и лечения инфекционного заболевания
DE60238554D1 (de) Vakzine gegen infektionskrankheiten
ATE432943T1 (de) Einschlusskörper als antigene für die orale impfung von tieren gegen csfv